JP2003522797A5 - - Google Patents

Download PDF

Info

Publication number
JP2003522797A5
JP2003522797A5 JP2001559478A JP2001559478A JP2003522797A5 JP 2003522797 A5 JP2003522797 A5 JP 2003522797A5 JP 2001559478 A JP2001559478 A JP 2001559478A JP 2001559478 A JP2001559478 A JP 2001559478A JP 2003522797 A5 JP2003522797 A5 JP 2003522797A5
Authority
JP
Japan
Prior art keywords
och
micelle
patient
aqueous solution
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001559478A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003522797A (ja
JP4959085B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/005297 external-priority patent/WO2001060382A1/en
Publication of JP2003522797A publication Critical patent/JP2003522797A/ja
Publication of JP2003522797A5 publication Critical patent/JP2003522797A5/ja
Application granted granted Critical
Publication of JP4959085B2 publication Critical patent/JP4959085B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001559478A 2000-02-18 2001-02-20 ミセル Expired - Lifetime JP4959085B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18376800P 2000-02-18 2000-02-18
US60/183,768 2000-02-18
PCT/US2001/005297 WO2001060382A1 (en) 2000-02-18 2001-02-20 Micelles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012025659A Division JP2012116860A (ja) 2000-02-18 2012-02-09 ミセル

Publications (3)

Publication Number Publication Date
JP2003522797A JP2003522797A (ja) 2003-07-29
JP2003522797A5 true JP2003522797A5 (enExample) 2011-11-04
JP4959085B2 JP4959085B2 (ja) 2012-06-20

Family

ID=22674206

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001559478A Expired - Lifetime JP4959085B2 (ja) 2000-02-18 2001-02-20 ミセル
JP2012025659A Pending JP2012116860A (ja) 2000-02-18 2012-02-09 ミセル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012025659A Pending JP2012116860A (ja) 2000-02-18 2012-02-09 ミセル

Country Status (10)

Country Link
US (3) US6906042B2 (enExample)
EP (2) EP2452684B1 (enExample)
JP (2) JP4959085B2 (enExample)
KR (1) KR100841813B1 (enExample)
AU (2) AU2001238507C9 (enExample)
CA (1) CA2400371C (enExample)
ES (1) ES2664818T3 (enExample)
HK (1) HK1052872A1 (enExample)
IL (2) IL151314A0 (enExample)
WO (1) WO2001060382A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030130212A1 (en) * 1999-01-14 2003-07-10 Rossignol Daniel P. Administration of an anti-endotoxin drug by intravenous infusion
AU2001238507C9 (en) * 2000-02-18 2005-07-07 Eisai R&D Management Co., Ltd. Micelles
JP4366081B2 (ja) * 2001-05-22 2009-11-18 エーザイ・アール・アンド・ディー・マネジメント株式会社 高度に精製されたアンチエンドトキシン化合物
US7727974B2 (en) 2001-08-10 2010-06-01 Eisai R & D Management Co., Ltd. Methods of reducing the severity of mucositis
WO2003013440A2 (en) * 2001-08-10 2003-02-20 Eisai Co., Ltd. Treatment and prevention of heat shock protein-associated diseases and conditions
WO2003082303A1 (en) * 2002-03-29 2003-10-09 Wisconsin Alumni Research Foundation Polymeric micelle formulations of hydrophobic compounds and methods
WO2004034992A2 (en) * 2002-10-15 2004-04-29 Wisconsin Alumni Research Foundation Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles
CA2536283A1 (en) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. Pharmaceutical preparations having an improved solubility
ATE446581T1 (de) * 2004-03-12 2009-11-15 Trinity College Dublin Magnetoresistives medium
WO2007026675A1 (ja) * 2005-08-31 2007-03-08 Eisai R & D Management Co., Ltd. リピッドa類縁体の製造方法
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070178049A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
JP2009526619A (ja) * 2006-02-15 2009-07-23 ティカ レーケメデル アーベー 質量減量を伴うコルチコステロイドの滅菌
BR112014024139A8 (pt) 2012-03-28 2018-01-16 Univ Maryland administração de eritoran ou sais farmaceuticamente aceitáveis do mesmo para tratar infecções de ortomixovírus
WO2018053073A1 (en) 2016-09-16 2018-03-22 Eisai R&D Management Co., Ltd. Method of use of eritoran as a tlr4 antagonist for treatment of ebola and marburg disease
BR112021010717A2 (pt) 2018-12-17 2021-08-31 Eisai R&D Management Co., Ltd. Formulação que compreende lipossomas
US11198831B2 (en) 2019-01-31 2021-12-14 Kvi Llc Lubricant for a device
WO2021207218A1 (en) 2020-04-06 2021-10-14 Eisai R&D Management Co., Ltd. Treatment of nidovirales infection with eritoran

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530113A (en) 1991-10-11 1996-06-25 Eisai Co., Ltd. Anti-endotoxin compounds
US6417172B1 (en) 1995-06-05 2002-07-09 Eisai Co., Ltd. Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
US5681824A (en) 1995-06-05 1997-10-28 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia
AU7254396A (en) * 1995-09-29 1997-04-17 Eisai Research Institute Method for treating alcoholic liver disease
JP4326030B2 (ja) * 1996-07-03 2009-09-02 エーザイ・アール・アンド・ディー・マネジメント株式会社 リピッドa類縁体含有注射用製剤及びその製造方法
US6235724B1 (en) * 1996-07-03 2001-05-22 Eisai Co., Ltd. Injections containing lipid a analogues and process for the preparation thereof
US6495532B1 (en) 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
JP2002501540A (ja) 1997-05-23 2002-01-15 エーザイ株式会社 製薬製剤を調製するための方法
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
EP1250141A4 (en) 2000-01-14 2007-05-16 Eisai Co Ltd Prevention and treatment of endotoxemia and related complications in the field of surgery
AU2001238507C9 (en) 2000-02-18 2005-07-07 Eisai R&D Management Co., Ltd. Micelles
US6861512B2 (en) 2000-03-01 2005-03-01 Eisai Co., Ltd. Separation of olefinic isomers
US20030105033A1 (en) 2000-06-09 2003-06-05 Rossignol Daniel P. Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
JP4179881B2 (ja) 2000-12-06 2008-11-12 エーザイ株式会社 凍結乾燥ケークの抵抗を測定するためのシステム及び方法
WO2002089743A2 (en) 2001-05-09 2002-11-14 The Regents Of The University Of Michigan Use of compositions for treating rosacea
US7727974B2 (en) 2001-08-10 2010-06-01 Eisai R & D Management Co., Ltd. Methods of reducing the severity of mucositis
AU2004218358A1 (en) 2003-03-05 2004-09-16 Eisai R&D Management Co., Ltd. Compositions and methods for preventing and treating endotoxin-related diseases and conditions

Similar Documents

Publication Publication Date Title
JP2003522797A5 (enExample)
US7989432B2 (en) Micelles
JP2000500160A (ja) 非水性結腸下剤処方物
KR101052705B1 (ko) 아미노글리코시드계 항생물질 및 브롬페낙을 함유하는수용액 제제
JP2010503731A5 (enExample)
JP6479485B2 (ja) 眼疾患治療用ナノ粒子製剤
DE60035429T2 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
EP0191792B1 (de) Prostacyclin-derivate mit zytoprotektiver wirkung an der niere
JP3040463B2 (ja) 抗血栓症作用を有する組合せ調剤
KR20190041233A (ko) 황산염을 포함하는 대장 하제 조성물
TWI422368B (zh) 治療慢性阻塞性肺疾之組成物
CA2103906C (en) Iloprost with action against cerebral malaria
WO2008066783A2 (en) Therapeutic materials and methods
TWI387454B (zh) 治療胃腸道疾病之方法及組成物
KR940703840A (ko) 치환 벤즈이미다졸, 그의 제조 방법 및 용도(substituted benzimidazoles, process for their preparation as well as their use)
DE4104607A1 (de) Prostacyclin- und carbacyclinderivate als mittel zur behandlung von fiebrigen erkrankungen
RU2488398C2 (ru) Фармацевтическая комбинация опиоида и простагландинового соединения
TW201500042A (zh) 與血液透析有關的低血壓的治療
US9084815B2 (en) Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
AU2002338038B2 (en) Aqueous ecabet sodium solution preparation
US20160271097A1 (en) Formulation of olopatadine
RU2022119027A (ru) Фармацевтическая композиция трициклического соединения двойного ингибитора фдэ3/фдэ4
HK40044330A (en) Solid preparation composition for oral administration of colonic purgative containing anhydrous sodium sulfate, potassium sulfate, anhydrous magnesium sulfate and simethicone
HK1096609A1 (zh) 用於治疗胃病的含有抗溃疡药和粘膜保护剂的药物组合物
HK1096609B (en) Pharmaceutical composition for treating gastric disease containing antiulcerent and mucosal protective agents